You searched for: induktionskemoterapien (Danska - Engelska)

hos patienter, som er i plateaufase (mere end 50 % reduktion af myelom-protein) efter initial induktionskemoterapi, kan interferon alfa-2b gives som monoterapi, subkutant i en dosering på 3 millioner ie/m2 tre gange om ugen (hver anden dag).
in patients who are in the plateau phase (more than 50 % reduction of myeloma protein) following initial induction chemotherapy, interferon alfa-2b may be administered as monotherapy, subcutaneously, at a dose of 3 million iu/m2 three times a week (every other day).